340B Leadership Visante actively participates in the 340B Winter Coalition Conference, signaling deep specialization in hospital pharmacy cost management. This focus helps health systems optimize 340B programs, improve compliance, and increase savings. Sales opportunities include 340B analytics, optimization services, and ongoing compliance support aligned with their footprint design capabilities.

Infusion Expansion At the 2025 MHA and Navigator Business Summit Visante highlighted the case for pharmacies expanding into home or alternate site infusion as a new line of business. This indicates client demand for end to end infusion program design, payer contracting guidance, and care workflows. Opportunities exist to offer infusion program setup, staffing models, logistics, and technology enablement.

Growth Readiness Visante reports revenue in a mid market range and a track record of delivering measurable financial gains, operational excellence, and enhanced patient experience. This suggests capacity for larger engagements and multi year partnerships in footprint redesigns, service expansions, and managed services. A sales approach could emphasize ROI driven projects and scalable solutions.

Leadership Expertise Erick Siegenthaler is a senior director and active presenter at industry events such as the conferences cited. This demonstrates strong thought leadership and credibility to win complex engagements. Leverage this leadership in co branded materials, executive outreach, and case studies to attract health systems seeking strategic pharmacy growth.

Tech and Compliance Visante relies on a modern tech stack including Zoho, Microsoft Excel, HIPAA compliance, and security tooling like Cloudflare. This foundation supports data driven analysis, secure data sharing, and scalable workflow design. Opportunities for sales include CRM and analytics integration, data automation, and compliance oriented services aligned with client needs.